Search the GHTC website
March 8, 2022

A call to scale up preventive malaria treatment for pregnant women in sub-Saharan Africa

On International Women's Day, Medicines for Malaria Venture calls for sustained action to address biases, discrimination, and inequities that affect women and girls, including their access to malaria prevention and treatment. 

June 21, 2021

Gender issues must not be an afterthought in global health research

A quick glance at the historical trajectory of malaria research reveals that it has been embedded in a larger context of gender bias in medical research. During the clinical development of most new medicines, including antimalarial drugs, pregnant people are actively excluded from trials. Fortunately, there is now growing determination within the malaria community to rectify gender-related data gaps.

June 7, 2019

Saving two lives, not just one: medicines for malaria during pregnancy

An estimated 125 million pregnancies around the world are at risk from malaria annually. For both mother and baby, the disease is potentially life-threatening and babies that do survive are often born with low birth weight, which is associated with negative impact on development.

November 26, 2018

As the global fight against malaria stalls, malaria vaccine development could be primed for breakout

While the global fight against malaria stalls, we are closer than ever to a world where malaria vaccines join the battle arsenal.